5FE-15502-11820
4 vaccinations
4 coded responses
28 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 620 / IL
- Registered
- 2021-01-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-28
Dose 1 — Pfizer-BioNTech
-
2021-01-29
Registered in v-safe
-
2021-01-29
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: Good · Site: PainFree text: VERY slight soreness at innoculation siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-11
- 2021-02-18
-
2021-02-22
Dose 2 — Pfizer-BioNTech
- 2021-02-25
- 2021-02-26
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-08
- 2021-03-15
- 2021-03-22
- 2021-03-29
- 2021-04-05
- 2021-05-24
- 2021-08-23
-
2021-10-04
Dose 3 — Pfizer-BioNTech
- 2022-02-22
-
2022-06-06
Dose 4 — Pfizer-BioNTech
- 2022-06-28
- 2022-07-04
-
2022-07-11
Survey response — day 35, dose 4MedDRA: Hordeolum, Medical counselling, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: I have a recurring stye in my eye (having NEVER had a stye previously). My ophthalmologist believes that it is due to wearing my mask. She said several technicians in her office also have developed styes due to wearing masks 8 hours a day. · Healthcare visit (other): Made an in office appointment with my ophthalmologistMedDRA releases: 2024-11 · check-in free text available
-
2022-07-11
Report sent to call center — day 35, dose 4Get care from a doctor or other healthcare professional1 call case(s)
-
2022-07-12
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-07-18
-
2022-09-05
Survey response — 3 months, dose 4MedDRA: COVID-19, SARS-CoV-2 test positive — Feeling: Good · Be unable to do your normal daily activitiesFree text: Covid. First positive test on 8/22/22.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-05
Survey response — 6 months, dose 4MedDRA: COVID-19, SARS-CoV-2 test positive — Feeling: Good · Be unable to do your normal daily activitiesFree text: I tested positive for Covid on August 22, 2022 (home test). I immediately started August 22 with a Paxlovid regiment. I believe it was instrumental in making my Covid bout shorter and less severe.MedDRA releases: 2024-11 · check-in free text available
- 2023-06-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-28 | Pfizer-BioNTech | |
| 2 | 2021-02-22 | Pfizer-BioNTech | |
| 3 | 2021-10-04 | Pfizer-BioNTech | No |
| 4 | 2022-06-06 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 3 — days 1–6 daily, dose 1
Systemic reaction (other): VERY slight soreness at innoculation site
Release 12 — day 35, dose 4
Symptoms: I have a recurring stye in my eye (having NEVER had a stye previously). My ophthalmologist believes that it is due to wearing my mask. She said several technicians in her office also have developed styes due to wearing masks 8 hours a day.
Healthcare visit (other): Made an in office appointment with my ophthalmologist
Release 12 — 3 months, dose 4
Symptoms: Covid. First positive test on 8/22/22.
Release 12 — 6 months, dose 4
Symptoms: I tested positive for Covid on August 22, 2022 (home test). I immediately started August 22 with a Paxlovid regiment. I believe it was instrumental in making my Covid bout shorter and less severe.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Hordeolum | · | · | ✓ |
| SD | Medical counselling | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release